Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Amgen's migraine drug succeeds in late-stage trial
Thursday, November 17, 2016Amgen Inc said on Wednesday its migraine treatment met the main goal of reducing monthly migraine days in patients with episodic migraine in a second latestage study Patients receiving milligram of the drug erenumab experienced reduction of days f...
Bristol-Myers Squibb and Enterome announce immuno-oncology collaboration
Thursday, November 17, 2016BristolMyers Squibb and Enterome announce immunooncology collaboration focused on microbiomederived biomarkersdrug targets bioactive molecules BristolMyers Squibb BristolMyers Squibb will be granted exclusive rights to intellectual property and the...
Amgen cholesterol drug reduces artery-clogging plaque in study
Wednesday, November 16, 2016Amgen Incs potent new drug Repatha when added to statin therapy not only took bad LDL cholesterol down to extremely low levels but caused declines in arteryclogging plaque in a majority of highrisk heart patients after months of treatment according...
Corbus drug succeeds in mid-stage scleroderma study, shares surge
Tuesday, November 15, 2016Corbus Pharmaceuticals Holdings Inc said its only drug outperformed a placebo in a midstage study involving patients with a form of systemic sclerosis an incurable autoimmune condition caused by abnormal growth of connective tissue Shares of the Nor...
Richter's generic osteoporosis drug gets EU recommendation
Tuesday, November 15, 2016Richter received a positive opinion from European regulators recommending that its generic osteoporosis drug Terrosa be granted marketing authorization the Hungarian drug maker said in a statement on Monday Richter said the drug was its first biosim...
Dynavax says U.S. FDA rejects its hepatitis B vaccine
Tuesday, November 15, 2016Dynavax Technologies Corp said on Monday the US Food and Drug Administration had rejected the marketing application for its hepatitis B vaccine HeplisavB sending the companys shares tumbling percent in premarket trading The drug developer said it r...
J&J arthritis drug goes up against Humira, with mixed results
Monday, November 14, 2016Johnson Johnson said its experimental sirukumab treatment for rheumatoid arthritis showed mixed results against AbbVie Incs topselling Humira in a large trial By one measure patients with moderate to severe disease who took sirukumab showed signifi...
Roche announces positive results for Actemra in phase III study
Monday, November 14, 2016Swiss drugmaker Roche said on Sunday its rheumatoid arthritis medication Actemra for giant cell arteritis showed to be superior to steroids alone in maintaining steroidfree remission in a Phase III study Results from the study showed that percent o...
Pfizer offers cut-price pneumonia shot for humanitarian crises
Saturday, November 12, 2016US pharmaceuticals giant Pfizer is to offer its pneumococcal vaccine at the lowest possible price to nongovernmental organizations seeking to protect vulnerable people from illness in humanitarian crises In what it called a major expansion of its hu...
Novo Nordisk receives positive opinion for Fiasp-drug in EU
Saturday, November 12, 2016Danish insulin maker Novo Nordisk Says receives positive opinion from the European regulatory authorities Committee for Medicinal Products for Human Use CHMP for Fiasp fastacting insulin aspart for the treatment of adults with type and type diabete...
